Search results
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 10 hours agoHC Wainwright reissued a “buy” rating and issued a $19.00 price objective on shares of Novavax in a research report on Monday, May 13th. TD Cowen raised their price objective ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 6 hours agoShares of vaccine stocks Moderna (MRNA 0.85%), Novavax (NVAX 3.17%), and BioNTech SE (BNTX -2.99%)...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 6 days ago*Stock Advisor returns as of May 13, 2024 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 4 days agoPrice Performance Review of NVAX On Friday, Novavax, Inc. [NASDAQ:NVAX] saw its stock fall -9.65% to $13.01. Over the last five days, the stock ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoNovavax reported positive developments in its latest quarterly update that doubled its share price...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 1 day agoCurrent RSI values indicate that the stock is may be overbought. Next earnings report is scheduled for 75 days from now. Professional Analyst Ratings for Novavax& ...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
